Tania Crombet
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 26
- Lung Cancer Research Studies 19
- HER2/EGFR in Cancer Research 13
- Otorhinolaryngology top 2%
- Immunology top 5%
- Immunotherapy and Immune Responses 25
-
- Lung Cancer Treatments and Mutations 22
- Genetics top 5%
-
- Glycosylation and Glycoproteins Research 18
-
- Monoclonal and Polyclonal Antibodies Research 16
-
- Cancer Research and Treatments 11
- Co-authors
- Rolando PérezAgustín LageJanusz RakAlicia Viloria‐PetitRobert S. KerbelElia NeningerPeter BöhlenS Jothy
- Journals
- Journal of Clinical Oncology (16 papers)SHILAP Revista de lepidopterología (2 papers)Cancer Research (1 paper)
- Partner nations
- CubaUnited StatesSpain
In The Last Decade
Tania Crombet
94 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 104
- Oncology 1.9k
- Otorhinolaryngology 235
- Immunology 844
- Pulmonary and Respiratory Medicine 1.0k
- Genetics 288
Countries citing papers authored by Tania Crombet
This map shows the geographic impact of Tania Crombet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Crombet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Crombet more than expected).
Fields of papers citing papers by Tania Crombet
This network shows the impact of papers produced by Tania Crombet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Crombet. The network helps show where Tania Crombet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tania Crombet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 8 | |
| 5 | Reposicionamiento del anticuerpo monoclonal humanizado anti-CD6 itolizumab en el tratamiento de pacientes con COVID-19 | 2021 | 0 |
| 6 | 2020 | 1 | |
| 7 | 2020 | 22 | |
| 8 | 2018 | 6 | |
| 9 | 2018 | 2 | |
| 10 | 2016 | 1 | |
| 11 | 2015 | 25 | |
| 12 | 2015 | 4 | |
| 13 | 2014 | 30 | |
| 14 | Agrupación familiar para el cáncer en individuos afectados por cáncer de pulmón | 2010 | 1 |
| 15 | 2010 | 36 | |
| 16 | CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer | 2009 | 4 |
| 17 | 2009 | 195 | |
| 18 | 2008 | 53 | |
| 19 | 2001 | 49 | |
| 20 | 2001 | 21 |
About Tania Crombet
Tania Crombet is a scholar working on Oncology, Immunology and Biotechnology, having authored 101 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), Immunotherapy and Immune Responses (25 papers), Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (19 papers), Glycosylation and Glycoproteins Research (18 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Research and Treatments (11 papers). The work is most often cited by research in Oncology (1.9k citations), Otorhinolaryngology (235 citations) and Immunology (844 citations). Tania Crombet has collaborated with scholars based in Cuba, United States and Spain. Frequent co-authors include Rolando Pérez, Agustín Lage, Janusz Rak, Alicia Viloria‐Petit, Robert S. Kerbel, Elia Neninger, Peter Böhlen, S Jothy, Jean-Marc Schlaeppi and Daniel J. Hicklin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.